CorMedix Inc is a biotechnology business based in the US. CorMedix shares (CRMD) are listed on the NASDAQ and all prices are listed in US Dollars. CorMedix employs 29 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in CorMedix
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

CorMedix stock price (NASDAQ: CRMD)
Use our graph to track the performance of CRMD stocks over time.CorMedix shares at a glance
Latest market close | $3.83 |
---|---|
52-week range | $2.65 - $7.15 |
50-day moving average | $3.35 |
200-day moving average | $4.44 |
Wall St. target price | $22.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.74 |
Buy CorMedix shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CorMedix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CorMedix price performance over time
Historical closes compared with the close of $3.83 from 2022-07-01
1 week (2022-06-28) | 7.58% |
---|---|
1 month (2022-06-01) | N/A |
3 months (2022-04-05) | -31.73% |
6 months (2022-01-05) | -19.03% |
1 year (2021-07-02) | -44.81% |
---|---|
2 years (2020-07-02) | -37.72% |
3 years (2019-07-05) | 9.19 |
5 years (2017-07-03) | 783.30% |
CorMedix financials
Revenue TTM | $110,311 |
---|---|
Gross profit TTM | $41,998 |
Return on assets TTM | -24.52% |
Return on equity TTM | -39.99% |
Profit margin | 0% |
Book value | $1.55 |
Market capitalisation | $149.8 million |
TTM: trailing 12 months
CorMedix share dividends
We're not expecting CorMedix to pay a dividend over the next 12 months.
Have CorMedix's shares ever split?
CorMedix's shares were split on a 1:5 basis on 25 March 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CorMedix shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for CorMedix shares which in turn could have impacted CorMedix's share price.
CorMedix share price volatility
Over the last 12 months, CorMedix's shares have ranged in value from as little as $2.65 up to $7.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CorMedix's is 2.4088. This would suggest that CorMedix's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CorMedix overview
CorMedix Inc. , a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc.
CorMedix in the news
CorMedix to Participate at the JMP Securities Life Sciences Conference
CorMedix to Participate at the JMP Securities Life Sciences Conference
Frequently asked questions
What percentage of CorMedix is owned by insiders or institutions?Currently 1.254% of CorMedix shares are held by insiders and 34.402% by institutions. How many people work for CorMedix?
Latest data suggests 29 work at CorMedix. When does the fiscal year end for CorMedix?
CorMedix's fiscal year ends in December. Where is CorMedix based?
CorMedix's address is: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922 What is CorMedix's ISIN number?
CorMedix's international securities identification number is: US21900C3088 What is CorMedix's CUSIP number?
CorMedix's Committee on Uniform Securities Identification Procedures number is: 21900C100
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert